JPRN-UMIN000025855招募中未知
An open-label uncontrolled trial of the efficacy and safety of a hug for promotion of relaxation in pediatric patients with severe motor and intellectual disabilities. - An open-label uncontrolled trial of the efficacy and safety of a hug for promotion of relaxation in patients with severe motor and intellectual disabilities.
ational Hospital Organization Shizuoka Institute of Epilepsy and Neurological Disorders0 个研究点目标入组 20 人开始时间: 2017年2月27日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 18years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Children for whom the principal investigator or other investigators decided not suitable for participation in this study. 2)Children who became multiple and severely handicapped due to traumas of traffic injury, etc.. 3)Children who need sustained continuous suction. 4)Children with a history of bone fracture within 3 years until the time of registration.
研究者
相似试验
已完成
2 期
An uncontrolled open-label study on the efficacy and safety of sirolimus for epileptic seizures associated with focal cortical dysplasia type-IIfocal cortical dysplasia (type-II)JPRN-UMIN000033504Hokkaido University Hospital Nishi-Niigata Chuo National Hospital National Center Hospital, NCNP Shizuoka Institute of Epilepsy and Neurological Disorders Okayama University Hospital16
已完成
不适用
An Open-label controlled Trial to Assess the Efficacy of Bisphosphonate in the Treatment of Coronary Artery Calcification in Nondialyzed Patients with Diabetic Nephropathy.Type 2 diabetic nephropathyJPRN-C000000250Department of Nephrology, Osaka University School of Medicine50
尚未招募
不适用
AX TrialNL-OMON21156MC110
进行中（未招募）
1 期
An open-label randomized trial of zanidatamab for advanced HER2positive biliary tract cancerCTIS2023-508219-21-00Jazz Pharmaceuticals Ireland Limited243
尚未招募
3 期
An open-label randomized trial of zanidatamab for advanced HER2-positive biliary tract cancerCTRI/2024/08/072371Jazz Pharmaceuticals Ireland Limited